首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1378754

肾去神经系统市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Renal Denervation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年，全球肾去神经系统市场规模达到3.18亿美元。展望未来， IMARC Group预计到2028年市场规模将达到23.62亿美元，2022-2028年复合年增长率（CAGR）为39.7%。

肾去神经术 (RDN) 是一种介入性手术，涉及透过导管消融肾动脉壁内的交感神经。它最大限度地破坏神经，降低肾素分泌，刺激尿钠，并改善肾臟血流动力学或血流量。因此，RDN 系统广泛用于治疗顽固性高血压病例，其中最佳治疗无法缓解患者的症状。

由于吸烟和饮酒的人数不断增加、不健康饮食模式的增加、久坐和忙碌的生活方式以及老年人口的不断增加，高血压等生活方式疾病的患病率显着上升，这是关键因素之一加强市场成长。除此之外，与RDN系统相关的优势，如快速恢復、安全、时间效率和成本效益，是另一个主要的成长诱导因素。此外，微创（MI）手术不断增长的需求也促进了市场的成长。微输液技术的引入、医疗保健基础设施的改善、研发（R&D）活动的增加以及系统监管批准申请数量的增加，也对市场成长产生了积极影响。儘管如此，由于冠状病毒病（COVID-19）病例激增，医院就诊次数减少以及选择性医疗程序的重新安排影响了市场成长。

本报告回答的关键问题：

迄今为止，全球肾臟去神经系统市场表现如何，未来几年将如何表现？
主要区域市场有哪些？
COVID-19 对全球去肾神经系统市场有何影响？
依产品类型分類的市场是怎么样的？
基于产品的市场区隔是什么？
基于技术的市场区隔是什么？
基于应用程式的市场区隔是什么？
基于最终用户的市场区隔是什么？
产业价值链的各个阶段是什么？
该行业的关键驱动因素和挑战是什么？
全球去肾神经系统市场的结构如何？谁是主要参与者？
产业竞争程度如何？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太地区
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 12 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 13 章：价值链分析

第 14 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 15 章：价格分析

第16章：竞争格局

市场结构
关键参与者
关键参与者简介
- Boston Scientific Group
- Kona Medical Inc.
- Medtronic Plc
- Mercator MedSystems
- ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
- Renal Dynamics
- St. Jude Medical Inc. (Abbott)
- Terumo Corporation

简介目录图表

Product Code: SR112023A2558

Abstract

The global renal denervation systems market size reached US$ 318 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,362 Million by 2028, exhibiting a growth rate (CAGR) of 39.7% during 2022-2028.

Renal denervation (RDN) is an interventional procedure that involves a catheter-based ablation of the sympathetic nerves within the renal artery wall. It maximizes nerve disruption, lowers renin secretion, stimulates natriuresis, and improves renal hemodynamics or blood flow. As a result, RDN systems are extensively used to treat refractory hypertension cases wherein optimal therapy cannot provide relief to the patients.

A significant rise in the prevalence of lifestyle diseases, such as hypertension, on account of the increasing number of individuals who smoke and consume alcohol, rising unhealthy dietary patterns, sedentary and hectic lifestyles, and the growing geriatric population represents, one of the key factors strengthening market growth. Apart from this, the advantages associated with the RDN system, such as fast recovery, safety, time efficiency and cost-effectiveness, are acting as another major growth-inducing factor. Furthermore, the escalating demand for minimally invasive (MI) surgery is also contributing to the growth of the market. The introduction of micro-infusion technology, improving healthcare infrastructure, increasing research and development (R&D) activities and the rising number of filings for regulatory approvals of the systems, are also creating a positive influence on the market growth. Although, a decline in the hospital visits and rescheduling of elective health procedures due to the surging cases of the coronavirus disease (COVID-19) have impacted the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global renal denervation systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, product, technology, application and end user.

Breakup by Product Type:

Catheters

Single Electrode Catheter

Multi Electrode Catheter

RF Generator

Nerve Modifying Agents

Breakup by Product:

Symplicity

Vessix (V2)

EnligHTN

Paradise

Iberis

Others

Breakup by Technology:

Ultrasound Ablation

Radiofrequency Ablation

Microinfusion

Breakup by Application:

Hypertension

Cardiac Disorders

Diabetes

Renal Failure

Others

Breakup by End User:

Diagnostic Centers and Hospitals

Ambulatory Care Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporation.

Key Questions Answered in This Report:

How has the global renal denervation systems market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global renal denervation systems market?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global renal denervation systems market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Renal Denervation Systems Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Catheters
- 6.1.1 Market Trends
- 6.1.2 Major Types
  - 6.1.2.1 Single Electrode Catheter
  - 6.1.2.2 Multi Electrode Catheter
- 6.1.3 Market Forecast
6.2 RF Generator
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Nerve Modifying Agents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Product

7.1 Symplicity
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Vessix (V2)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 EnligHTN
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Paradise
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Iberis
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Technology

8.1 Ultrasound Ablation
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Radiofrequency Ablation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Microinfusion
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Application

9.1 Hypertension
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Cardiac Disorders
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Diabetes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Renal Failure
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast

10 Market Breakup by End User

10.1 Diagnostic Centers and Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Ambulatory Care Centers
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Boston Scientific Group
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Kona Medical Inc.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
- 16.3.3 Medtronic Plc
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
  - 16.3.3.4 SWOT Analysis
- 16.3.4 Mercator MedSystems
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
- 16.3.5 ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 Renal Dynamics
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 St. Jude Medical Inc. (Abbott)
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
- 16.3.8 Terumo Corporation
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Renal Denervation Systems Market: Major Drivers and Challenges
Figure 2: Global: Renal Denervation Systems Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Renal Denervation Systems Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Renal Denervation Systems Market: Breakup by Product (in %), 2022
Figure 5: Global: Renal Denervation Systems Market: Breakup by Technology (in %), 2022
Figure 6: Global: Renal Denervation Systems Market: Breakup by Application (in %), 2022
Figure 7: Global: Renal Denervation Systems Market: Breakup by End User (in %), 2022
Figure 8: Global: Renal Denervation Systems Market: Breakup by Region (in %), 2022
Figure 9: Global: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Renal Denervation Systems (Catheters) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Renal Denervation Systems (Catheters) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Renal Denervation Systems (RF Generator) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Renal Denervation Systems (RF Generator) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Renal Denervation Systems (Nerve Modifying Agents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Renal Denervation Systems (Nerve Modifying Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Renal Denervation Systems (Symplicity) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Renal Denervation Systems (Symplicity) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Renal Denervation Systems (Vessix- V2) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Renal Denervation Systems (Vessix- V2) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Renal Denervation Systems (EnligHTN) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Renal Denervation Systems (EnligHTN) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Renal Denervation Systems (Paradise) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Renal Denervation Systems (Paradise) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Renal Denervation Systems (Iberis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Renal Denervation Systems (Iberis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Renal Denervation Systems (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Renal Denervation Systems (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Renal Denervation Systems (Ultrasound Ablation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Renal Denervation Systems (Ultrasound Ablation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Renal Denervation Systems (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Renal Denervation Systems (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Renal Denervation Systems (Microinfusion) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Renal Denervation Systems (Microinfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Renal Denervation Systems (Hypertension) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Renal Denervation Systems (Hypertension) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Renal Denervation Systems (Cardiac Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Renal Denervation Systems (Cardiac Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Renal Denervation Systems (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Renal Denervation Systems (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Renal Denervation Systems (Renal Failure) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Renal Denervation Systems (Renal Failure) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Renal Denervation Systems (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Renal Denervation Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Renal Denervation Systems (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Renal Denervation Systems (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Renal Denervation Systems (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Renal Denervation Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: North America: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: North America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: United States: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: United States: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Canada: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Canada: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Asia Pacific: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Asia Pacific: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: China: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: China: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Japan: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Japan: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: India: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: India: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: South Korea: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: South Korea: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Australia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Australia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Indonesia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Indonesia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Europe: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Europe: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Germany: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Germany: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: France: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: France: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: United Kingdom: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: United Kingdom: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Italy: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Italy: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Spain: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Spain: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Russia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Russia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Latin America: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Latin America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Brazil: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Brazil: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Mexico: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Mexico: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Middle East and Africa: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Middle East and Africa: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 98: Global: Renal Denervation Systems Industry: SWOT Analysis
Figure 99: Global: Renal Denervation Systems Industry: Value Chain Analysis
Figure 100: Global: Renal Denervation Systems Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Renal Denervation Systems Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Renal Denervation Systems Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Renal Denervation Systems Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Renal Denervation Systems Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 5: Global: Renal Denervation Systems Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Renal Denervation Systems Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 7: Global: Renal Denervation Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Renal Denervation Systems Market Structure
Table 9: Global: Renal Denervation Systems Market: Key Players

02-2729-4219

+886-2-2729-4219